Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00076557
What this trial is testing

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

Who this might be right for
Hemophilia B
Avigen 15
Post-approval studies (Phase 4)Study completedNCT00139828
What this trial is testing

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Who this might be right for
Hemophilia B
Prothya Biosolutions 12
Not applicableActive Not RecruitingNCT05086575
What this trial is testing

Observatory of Patients With Haemophilia B Treated by IdElvion®

Who this might be right for
Haemophilia B
CSL Behring 222
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Not applicableStudy completedNCT01510418
What this trial is testing

Socialization of Adult Men With Congenital Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Dana-Farber Cancer Institute 27
Large-scale testing (Phase 3)Study completedNCT01395810
What this trial is testing

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 71
Not applicableStudy completedNCT00581438
What this trial is testing

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

Who this might be right for
Hemophilia AHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 52
Large-scale testing (Phase 3)Study completedNCT00141843
What this trial is testing

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 100
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Not applicableEnrolling By InvitationNCT03690336
What this trial is testing

Adverse Event Data Collection From External Registries on Nonacog Beta Pegol

Who this might be right for
Haemophilia B
Novo Nordisk A/S 10
Large-scale testing (Phase 3)Study completedNCT02053792
What this trial is testing

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 97
Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Not applicableLooking for participantsNCT06008938
What this trial is testing

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 500
Early research (Phase 1)Study completedNCT00956345
What this trial is testing

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 18
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT00882778
What this trial is testing

PROPACT: Retrospective Prophylaxis Patient Case Collection

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 86
Early research (Phase 1)Study completedNCT01288391
What this trial is testing

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation